Category 18
Emerging Research and Future Developments
12 topics planned. Each topic is published as a Professional and Patient edition only after explicit author approval.
- 18.1MSC engineeringIn preparation
- · Genetic modification
- · RNA engineering
- · Surface modification
- · Homing enhancement
- · Suicide switches
- · Safety controls
- 18.2MSC primingIn preparation
- · Hypoxia
- · Inflammatory cytokines
- · Mechanical stimulation
- · Pharmacological priming
- · Three-dimensional culture
- · Disease-specific conditioning
- 18.3Advanced manufacturingIn preparation
- · Closed automated systems
- · Continuous manufacturing
- · Large-scale bioreactors
- · Real-time monitoring
- · Process analytical technology
- · Artificial intelligence in quality control
- 18.4Engineered EVsIn preparation
- · Cargo loading
- · Surface targeting
- · RNA delivery
- · Protein delivery
- · Drug delivery
- · Synthetic and hybrid vesicles
- 18.5EV biomarkersIn preparation
- · Cancer detection
- · Neurological disease
- · Cardiovascular disease
- · Transplant monitoring
- · Treatment response
- · Liquid biopsy
- 18.6Tissue engineeringIn preparation
- · Biomaterial scaffolds
- · Hydrogels
- · Decellularized matrix
- · Bioprinting
- · Vascularized constructs
- · Organoid transplantation
- 18.7Pluripotent-cell-derived therapiesIn preparation
- · Retinal cells
- · Dopaminergic neurons
- · Cardiomyocytes
- · Pancreatic beta cells
- · Immune cells
- · Safety and tumorigenicity
- 18.8Organoids and disease modelsIn preparation
- · Developmental biology
- · Drug screening
- · Personalized medicine
- · Toxicology
- · Organoid transplantation
- · Ethical issues
- 18.9Precision regenerative medicineIn preparation
- · Patient stratification
- · Biomarker-guided therapy
- · Pharmacogenomics
- · Immune profiling
- · Digital endpoints
- · Individualized potency testing
- 18.10Better clinical trialsIn preparation
- · Adaptive designs
- · Platform trials
- · Master protocols
- · Standardized core outcomes
- · International registries
- · Long-term surveillance networks
- 18.11Future regulatory challengesIn preparation
- · Engineered cells
- · Combination products
- · Decentralized manufacturing
- · Personalized batches
- · Artificial EVs
- · Cross-border treatment
- 18.12Realistic future outlookIn preparation
- · Scientific opportunities
- · Translational bottlenecks
- · Manufacturing barriers
- · Affordability
- · Evidence requirements
- · Preventing hype from outrunning data